transcription factor AP-2 beta
آخر تحديث 2 مايو 2023
يتوافق مع الإرشادات التحريرية
- تنزيلتنزيل
- مشاركة
- Language
- نقاش
- Ask Patient
- نسخة صوتية
- أضف إلى المصادر المفضلة على جوجل
ال TFAP2B gene provides instructions for making a protein called transcription factor AP-2β. A transcription factor is a protein that attaches (binds) to specific regions of DNA and helps control the activity of particular genes. Transcription factor AP-2β is one of a group of related proteins called AP-2 transcription factors. These proteins regulate genes that help control cell division and the self-destruction of cells that are no longer needed (apoptosis).
اختيارات الفيديو لـ Genesمكتبة الفيديو
Normal function
ال TFAP2B gene provides instructions for making a protein called transcription factor AP-2β. A transcription factor is a protein that attaches (binds) to specific regions of DNA and helps control the activity of particular genes. Transcription factor AP-2β is one of a group of related proteins called AP-2 transcription factors. These proteins regulate genes that help control cell division and the self-destruction of cells that are no longer needed (apoptosis).
Transcription factor AP-2β is involved in development before birth. In particular, this protein is active in the neural crest, which is a group of cells in the early embryo that give rise to many tissues and organs. Neural crest cells migrate to form portions of the nervous system, glands that produce hormones (endocrine glands), pigment cells, smooth muscle and other tissues in the heart, and many tissues in the face and skull. Transcription factor AP-2β also appears to play an important role in the development of the limbs.
Conditions referring to this gene or chromosome
Other names
activating enhancer binding protein 2 beta
AP-2B
AP2-B
AP2-beta
AP2B_HUMAN
MGC21381
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
Related patient information and medicines

Patient information leaflet
هل يمكنني تناول أبيكسابان وبيسوبرولول معًا؟
They work in different ways and do not interfere with how the body processes each other. Why this happens أبيكسابان هو anticoagulant (blood thinner) that works by blocking a clotting factor called Factor Xa. Bisoprolol is a beta-blocker that slows the heart rate and lowers blood pressure. They are processed by different pathways in the liver and.

Patient information leaflet
هل يمكنني تناول أبيكسابان وميتفورمين معًا؟
They are generally safe to take together. Why this happens أبيكسابان هو a blood thinner (anticoagulant) and metformin هو a medicine for type 2 diabetes. They work in completely different ways in the body and are processed by different organs and enzymes, so they do not interfere with each other. Our مدقق تفاعلات الأدوية helps you check.

Patient information leaflet
هل يمكنني تناول بيسوبرولول وتريمبو معًا؟
It also makes the formoterol in the Trimbow inhaler less effective at opening your airways. Why this happens بيسوبرولول هو a 'beta-blocker' and formoterol (in Trimbow) is a 'beta-agonist'. They compete for the same receptors in the lungs. Important precautions Acute التنفس distress Bisoprolol is a beta-blocker and can cause narrowing of the.

Patient information leaflet
الرجفان الأذيني
Several medicines can slow the heart rate down. They include beta-blocker Beta-blockers medicines (such as atenolol Atenolol - a beta-blocker and propranolol Propranolol - a beta-blocker ), calcium-channel blocker medicines Calcium channel blockers (such as diltiazem Diltiazem and verapamil Verapamil - a calcium-channel blocker ) and digoxin.

Patient information leaflet
هل يمكنني تناول أبيكسابان وريبيلسوس معًا؟
These two medicines work in different ways and do not typically interfere with how the other is absorbed, broken down, or removed from the body. Why this happens أبيكسابان هو anticoagulant (blood thinner) that works by blocking أ clotting factor called Factor Xa. Rybelsus is a GLP-1 receptor agonist used for type 2 diabetes that mimics a natural.

Patient information leaflet
هل يمكنني تناول أبيكسابان ومكملات الألياف معًا؟
It is best to stick to moderate drinking limits. Using other medicines Taking multiple medicines. Our Medicines Interaction Checker helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Simply search for your medicines to see potential interactions and what to do about them. Disclaimer.
قراءة إضافية ومراجع
- transcription factor AP-2 beta; MedlinePlus, National Library of Medicine.
- Hilger-Eversheim K, Moser M, Schorle H, Buettner R. Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene. 2000 Dec 30;260(1-2):1-12. doi: 10.1016/s0378-1119(00)00454-6.
- Maeda S, Tsukada S, Kanazawa A, Sekine A, Tsunoda T, Koya D, Maegawa H, Kashiwagi A, Babazono T, Matsuda M, Tanaka Y, Fujioka T, Hirose H, Eguchi T, Ohno Y, Groves CJ, Hattersley AT, Hitman GA, Walker M, Kaku K, Iwamoto Y, Kawamori R, Kikkawa R, Kamatani N, McCarthy MI, Nakamura Y. Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus. J Hum Genet. 2005;50(6):283-292. doi: 10.1007/s10038-005-0253-9. Epub 2005 Jun 7.
- Mani A, Radhakrishnan J, Farhi A, Carew KS, Warnes CA, Nelson-Williams C, Day RW, Pober B, State MW, Lifton RP. Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder. Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2975-9. doi: 10.1073/pnas.0409852102. Epub 2005 Jan 31.
- Satoda M, Zhao F, Diaz GA, Burn J, Goodship J, Davidson HR, Pierpont ME, Gelb BD. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet. 2000 May;25(1):42-6. doi: 10.1038/75578.
- Tsukada S, Tanaka Y, Maegawa H, Kashiwagi A, Kawamori R, Maeda S. Intronic polymorphisms within TFAP2B regulate transcriptional activity and affect adipocytokine gene expression in differentiated adipocytes. Mol Endocrinol. 2006 May;20(5):1104-11. doi: 10.1210/me.2005-0311. Epub 2005 Dec 22.
- Zhao F, Weismann CG, Satoda M, Pierpont ME, Sweeney E, Thompson EM, Gelb BD. Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation. Am J Hum Genet. 2001 Oct;69(4):695-703. doi: 10.1086/323410. Epub 2001 Aug 14.
تاريخ المقال
المقال متاح أيضًا باللغة الإنجليزية, الألمانية, إسبانية, الفرنسية, إيطالي, البرتغالية, الهندية, العبرية, العربية ,، و السويدية.
2 مايو 2023 | أحدث إصدار
1 Aug 2022 | نُشر في الأصل
شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.
اشترك في النشرة الإخبارية للمرضى
جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.
من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.

